D-0375-2022 Class I Terminated
FDA drug recall D-0375-2022 was initiated by Taro Pharmaceuticals U.S.A., Inc. on December 15, 2021 and is designated Class I. Reason for recall: Microbial Contamination of Non-Sterile Products: presence of R. Pickettii bacteria The recall status is terminated (terminated December 4, 2023). Affected quantity: 96 tubes.
Recall Details
- Product Type
- Drugs
- Report Date
- January 19, 2022
- Initiation Date
- December 15, 2021
- Termination Date
- December 4, 2023
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 96 tubes
Product Description
Clobetasol Propionate Ointment USP, 0.05%, 60g tubes, Rx only, Mfd. by: Taro Pharmaceutical Industries Ltd., Haifa Bay, Israel 2624761, Dist. by: Taro Pharmaceuticals U.S.A., Inc., Hawthorne, NY 10532. NDC 51672-1259-3
Reason for Recall
Microbial Contamination of Non-Sterile Products: presence of R. Pickettii bacteria
Distribution Pattern
Two distributors in UT and LA who could have further distributed to the retail level nationwide in the USA.
Code Information
Lot# AC13786, exp. date DEC 2022